Stay updated on BLASST-1: Nivolumab Combo in MIBC Clinical Trial
Sign up to get notified when there's something new on the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page.

Latest updates to the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference3%

- Check35 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check49 days agoChange DetectedVersion updated to v3.0.2; the v3.0.1 reference is removed, and the Back to Top element was deleted.SummaryDifference0.2%

- Check57 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check64 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as a comprehensive list of chemical compounds and proteins, while removing several specific terms related to antineoplastic agents and location details.SummaryDifference3%

- Check78 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%

Stay in the know with updates to BLASST-1: Nivolumab Combo in MIBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BLASST-1: Nivolumab Combo in MIBC Clinical Trial page.